26 September 2017 : Original article
Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Fumiaki Kitazawa1ABCDEF, Shin-ichi Fuchida2ABDE, Yoko Kado1BE, Kumi Ueda1E, Takatoshi Kokufu1DE, Akira Okano2D, Mayumi Hatsuse2D, Satoshi Murakami2D, Yuko Nakayama3DEF, Kohji Takara3ACDEF, Chihiro Shimazaki2DEFDOI: 10.12659/AOT.904505
Ann Transplant 2017; 22:575-580
Abstract
BACKGROUND: Tacrolimus and fentanyl are well-known cytochrome P450 (CYP) 3A4 substrates with a narrow therapeutic range. However, the pharmacokinetic interaction between tacrolimus and fentanyl is unclear. The aim of this study was to determine whether drug interaction exists between tacrolimus and fentanyl.
MATERIAL AND METHODS: A retrospective study was performed in 6 patients who had received allogeneic hematopoietic stem cell transplantation between April 2010 and March 2015. The patients received continuous intravenous infusion of fentanyl with concomitant use of tacrolimus, and the blood concentrations of tacrolimus were evaluated using fluorescence polarization immunoassay.
RESULTS: The clearance (CL) of tacrolimus decreased significantly from 1.28 to 0.68 mL/min/kg with concomitant use of fentanyl. The CL changed with time and dose of fentanyl administration. In addition, the CL of tacrolimus was reverted by stopping fentanyl infusion. Horn’s drug interaction probability scale indicated a probable category or possible category, suggesting a drug interaction between tacrolimus and fentanyl. No patient showed a difference in hepatic or renal function before and after fentanyl administration. No additional administration of other CYP3A4 inhibitors was observed, suggesting that the drug interaction was mediated by CYP3A4.
CONCLUSIONS: The influence of fentanyl on the pharmacokinetics of tacrolimus was demonstrated to be of clinical importance. It is proposed that the dose of tacrolimus be reduced by 40% when used in combination with fentanyl.
Keywords: Cytochrome P-450 CYP3A, Drug Interactions, Fentanyl, Metabolic Clearance Rate, Tacrolimus
Most Viewed Current Articles
24 Aug 2021 : Review article 22,612
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Sep 2015 : Review article 19,077
Risk Factors for Chronic Renal Insufficiency Following Cardiac TransplantationDOI :10.12659/AOT.893788
Ann Transplant 2015; 20:576-587
29 Dec 2021 : Original article 18,770
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
11 Aug 2015 : Original article 17,593
Twelve-Hour Hypothermic Machine Perfusion for Donor Heart Preservation Leads to Improved Ultrastructural Ch...DOI :10.12659/AOT.893784
Ann Transplant 2015; 20:461-468






